Clinical trial

A Study of Retreatment With Rituximab in Patients With Rheumatoid Arthritis Receiving Background Methotrexate

NCT00266227

Drugs and interventions used in this trial

4 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention placebo Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record rituximab Normalized identity: rituximabView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record methotrexate Normalized identity: methotrexateView linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention folate Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

A Study of Retreatment With Rituximab in Patients With Rheumatoid Arthritis Receiving Background Methotrexate

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2006-01-01

PhasePHASE3

Conditions

Rheumatoid Arthritisverified · MONDO: rheumatoid arthritis

Interventions

placeboDRUG

rituximabDRUG · verified · RxNorm: rituximab

methotrexateDRUG · verified · RxNorm: methotrexate

folateDRUG

Sponsors & collaborators

Genentech, Inc.lead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00266227 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.